Item 5. Implementation of the international drug control treaties (continued) (a) Changes in the scope of control of substances Chair: We are waiting for the delegation from WHO to present the substances. I have the pleasure to invite Mr, to present substances: N-pyrrolidino isotonitazene and N-desethyl etonitazene to be placed in.Schedule I from the single …
Morocco
Reconvened 68th session of the CND – 5 December 2025
Chair CND: Yesterday we considered the consolidated budget for 2026-2027. I understand that there have been informal consultations during which the draft resolution was amended. The amended text of the draft resolution after these informal consultations was circulated via special message on 22nd November and agreed upon by silence procedure on 25th November. May I …
Plenary – Friday morning session
CND Chair. Today is the last day of our deliberations. Before we start, it’s wonderful to see you all here again. We had 4 days of productive, engaging discussions, wide-ranging conversations on a wide range of issues. We heard from CSOs and other stakeholders, and you had productive and meaningful deliberations. I will only make …
Plenary – Thursday morning session
Item 6. Follow-up to the implementation at the national, regional and international levels of all commitments, as reflected in the Ministerial Declaration of 2019, to address and counter the world drug problem (continued) United States: The US takes the floor to address statements made yesterday regarding the mandate of the INCB which we do not …
Plenary — Wednesday afternoon session
Youth Forum: Your excellencies, distinguished delegates, ladies and gentleman. From 25 countries we gather as a unified voice to address the issue of substance use in our communities. This is not a new challenge and has been tackled over the past decades. Everyday there are new substances threatening individuals and society as a whole. It …
Committee of the Whole – Wednesday afternoon
L3. Promoting research on evidence-based interventions for the treatment and care of stimulant use disorders E/CN.7/2025/L.3 (…) Chair: There are several paragraphs in this document that have been agreed during informals, so we will go through those first. PP1 Agreed in CoW. PP4 Agreed in CoW. PP5 Agreed in CoW PP8 Agreed in CoW PP10 …